Sentinel surveillance of Lyme disease risk in Canada, 2019: Results from the first year of the Canadian Lyme Sentinel Network (CaLSeN)
Camille Guillot, J Badcock, Katie M. Clow, Jennifer Cram, Shaun J. Dergousoff, Antonia Dibernardo, Michelle Evason, Erin Fraser, Eleni Galanis, Salima Gasmi, Greg J. German, Douglas T Howse, Claire M. Jardine, Emily Jenkins, Jules K. Koffi, Manisha A. Kulkarni, L. Robbin Lindsay, Genevieve Lumsden, Roman McKay, Muhammad Morshed, Douglas Munn, Mark P. Nelder, Joe R. Nocera, Marion Ripoche, Kateryn Rochon, Curtis Russell, Andreea M. Slatculescu, Benoit Talbot, Karine Thivierge, Maarten J. Voordouw, Catherine Bouchard, Patrick A. Leighton
Abstract
BACKGROUND: Lyme disease is an emerging vector-borne zoonotic disease of increasing public health importance in Canada. As part of its mandate, the Canadian Lyme Disease Research Network (CLyDRN) launched a pan-Canadian sentinel surveillance initiative, the Canadian Lyme Sentinel Network (CaLSeN), in 2019. OBJECTIVES: To create a standardized, national sentinel surveillance network providing a real-time portrait of the evolving environmental risk of Lyme disease in each province. METHODS: and Powassan virus. RESULTS: in Nova Scotia. CONCLUSION: CaLSeN provides the first coordinated national active surveillance initiative for tick-borne disease in Canada. Through multidisciplinary collaborations between experts in each province, the pilot year was successful in establishing a baseline for Lyme disease risk across the country, allowing future trends to be detected and studied.